Founded at the Abramson Cancer Center at the University of Pennsylvania

Advances in therapeutic options for newly diagnosed, high-risk AML patients

Advances in therapeutic options for newly diagnosed, high-risk AML patients

Kimberley Doucette; Judith Karp; Catherine Lai

Therapeutic Advances in Hematology | 2021